Detalles de la búsqueda
1.
Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma.
Int J Cancer
; 136(5): E340-50, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25066666
2.
Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation.
Apoptosis
; 20(4): 535-50, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25627260
3.
Quality of life in long-term cervical cancer survivors: a population-based study.
Gynecol Oncol
; 129(1): 222-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23280088
4.
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
J Exp Clin Cancer Res
; 42(1): 260, 2023 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803448
5.
Health-related quality of life among long-term survivors of colorectal cancer: a population-based study.
Oncologist
; 16(11): 1626-36, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21987427
6.
Long-term quality of life after breast cancer: a French registry-based controlled study.
Breast Cancer Res Treat
; 129(1): 125-34, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21340477
7.
The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
Mol Oncol
; 15(12): 3659-3678, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160887
8.
Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects.
Cancers (Basel)
; 13(16)2021 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439123
9.
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
Carcinogenesis
; 31(6): 984-93, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20142415
10.
Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.
Cell Death Dis
; 11(5): 380, 2020 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424251
11.
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids.
Mol Cancer Ther
; 19(7): 1506-1519, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32371581
12.
Inhibition of store-operated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to anti-BclxL strategies through Mcl-1 down-regulation.
Oncotarget
; 9(74): 33896-33911, 2018 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338034
13.
The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.
Mol Cancer Ther
; 16(1): 102-115, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27980105
14.
PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced.
Cancer Lett
; 348(1-2): 38-49, 2014 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24650799
15.
Sensitization of ovarian carcinoma cells to Bcl-xL-targeting strategies through indirect modulation of Mcl-1 activity by MR22388, a molecule of the tripentone family.
J Ovarian Res
; 6(1): 38, 2013 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23735052
Resultados
1 -
15
de 15
1
Próxima >
>>